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ABSTRACT
Background: Disorders of serum sodium concentration are some of the most electrolyte abnormalities in the intensive care unit (ICU) 
patients. These disorders adversely affect the function of vital organs and are associated with increased hospital mortality. Purpose: In 
the present study we aimed to evaluate the effects of serum sodium concentration abnormalities at the time of hospital admission on the 
clinical outcome of therapy in a cohort of critically ill poisoned patients. Methods: In this cross-sectional study, 184 critically ill poisoned 
patients aged >18 years and in the first 8 hours of their poisoning, hospitalized in the ICU of a tertiary care university hospital (Isfahan, 
Iran) between 2010-2012, were evaluated at the admission time and 24 hours later for serum sodium concentration abnormalities and its 
relationship with age, gender, consciousness status, ingested drugs and clinical outcome of therapy. The clinical outcome was considered 
as recovery and mortality. Logistic Regression analysis was performed for predictive variables including serum sodium concentration 
abnormalities in patients’ clinical outcome. Findings: On admission, 152 patients (82.6%) were eunatremic, 21 patients (11.4%) were 
hyponatremic and 11 patients (6%) were hypernatremic. In the second day eunatremia, hyponatremia and hypernatremia was observed 
in 84.4%, 13% and 2.2% respectively. Age (OR=1.92; CI=1.18-3.12) and severity of toxicity (OR=1.32; CI=1.12-2.41) were predicting factors 
of mortality in ICU poisoning patients. Conclusions: Serum sodium concentration abnormalities are prevalent in critically ill poisoned 
patient but do not seem to have a predictive value for the clinical outcome of therapy.
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1. INTRODUCTION
Disorders of serum sodium concentration are some 
of the most electrolyte abnormalities in critically ill poi-
soned patients (1). These disorders adversely affect the 
function of vital organs and are associated with increased 
hospital mortality (2).
Hyponatremia is caused by sodium loss or water reten-
tion (due to congestive heart failure, inadequate secretion 
of antidiuretic hormone, polydipsia, renal failure and liver 
failure) or both of them (3). Hyponatremia may present 
with decrease of blood osmolality, muscle cramp, fatigue, 
nausea, vomiting, and spasm and headache. Signs and 
symptoms related to brain edema include convulsion, 
delusion, loss of consciousness and coma (4). Hyperna-
tremia is another electrolyte abnormality with less prev-
alence than hyponatremia (5). This disorder is caused by 
water loss from kidney or GI, thirst disturbance and inap-
propriate treatment with hypertonic liquids or diuretics 
(6, 7). This disorder occurs in 6-26% of patients in hos-
pitalization period in ICU and associates with increased 
mortality (8, 9).
Both hypo and hypernatremia are also seen in poisoned 
patients (10). Toxicity with cathartics, lithium, sodium 
chloride, sodium bicarbonate and sodium valproate cause 
hypernatremia (11-13). Hypernatremia also has been re-
ported on poisoning with chlorpropamide, ecstasy, phe-
nothiazines and amitriptyline (12, 14, and 15). Consump-
tion of drugs such trazodon and ecstasy are associated 
with hyponatremia with their effect on antidiuretic hor-
mone (16, 17).
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Studies about possible related factors with serum sodi-
um concentration abnormalities in poisonings are limit-
ed. Rosenson and coworkers in evaluation of 1436 case 
of ecstasy poisoning found that hyponatremia is more 
common in females (16). Carbamazepine also can causes 
hyponatremia, although its effect is weak alone and fac-
tors such as age (more than 40 years), surgery and men-
struation are related with increasing in its prevalence (18).
Some studies have been previously done on serum so-
dium concentration abnormalities in the intensive care 
unit (ICU) patients with other etiologies (1, 2, 19-22), but 
study of these abnormalities and their effect on prognosis 
in poisoned patients have not been done. Poisoned pa-
tients don’t have underlying disease mostly. In addition to 
kind of ingested drugs, factors such as vomiting, gastric 
lavage and treatment (alkaline diuresis) are also import-
ant in occurrence of serum sodium concentration disor-
ders. The aim of present study was evaluation of the effect 
of serum sodium concentration abnormalities at the time 
of hospital admission on the clinical outcome of therapy 
in a cohort of critically ill poisoned patients in a tertiary 
care referral university hospital in Iran.
2. MATERIALS AND METHODS
This cross-sectional study was done in the department 
of toxicological emergencies of Noor and Ali-Asghar 
[PBUH] University hospital affiliated to the Isfahan Uni-
versity of Medical Sciences, Isfahan from September 2010 
to June 2012. This center which is the major referral med-
ical center for toxicological emergencies for the central 
part of Iran, is facilitated, staffed and designed for the 
management of poisoned patients and approximately 400 
poisoned patients are admitted to it monthly.
The study protocol was approved by the institutional 
board of human studies at Isfahan University of Medical 
Sciences. In addition, after the study was accurately ex-
plained to each patient, informed consent was taken from 
them for inclusion to this study. If the patient was not able 
or had not the capacity for decision making, informed 
consent for inclusion to this study were taken from the 
patients’ first degree family.
All patients aged more than 18 years old admitted in 
the first 8 hour of poisoning during the time period of the 
study were recruited. Patients with SIADH or cancer and 
patients whom were referred from other hospitals to our 
center were not included in the study.
On ICU admission, venous blood sampling was taken 
for determining sodium level and also 24 hours later as 
well as other routine para-clinical tests. Vital signs and 
clinical manifestations were recorded for all patients. 
Age, ingested drugs, vomiting after poisoning, perform-
ing gastric lavage/ charcoal administration, alkaline di-
uresis , poisoning severity score (23), and consciousness 
status were investigated and recorded at the time of ICU 
admission as well. Outcome of patients were considered 
as recovery or death.
Patients were categorized in three groups based on 
their serum sodium level at the time of ICU admission (1) 
as: 1.hyponatremic: Na<135meq/L 2.eunatremic: 135< Na 
< 145 3.hypernatremic: Na > 145meq/L.
Statistical analysis of data was performed by chi-square 
or fisher exact test for comparing of serum sodium con-
centration abnormalities based on age, sex, and vomiting 
after poisoning. Wilcoxon signed ranks was used to com-
pare serum sodium level on admission day and 24 hours 
later.
Also logistic regression analysis was used for investigat-
ing role of different variables on patients’ outcome. P val-
ue less than 0.05 was considered as statistically significant 
difference between groups. All analyses were performed 
by SPSS 16 (SPSS Inc., Chicago, IL, USA).
3. RESULTS
According to the inclusion criteria, 184 patients were 
completely evaluated. Patients aged from 18 to 90 years 
(mean SD: 33.514.3). 51.1% of the patients were male. 
The most common cause of poisoning was opiate toxicity 
(25%). (Table1).
Mean serum sodium level was 138.1 (SD=14.9) on ad-
mission. 82.6% patients were eunatremic, 11.4% hypona-
tremic and 6% hypernatremic. 24 hours after admission, 
mean serum sodium level was 135.2 (SD=14.3) with prev-
alence of eunatremia 84.4%, hypernatremia 2.2% and hy-
ponatremia 13%. Although there was a statistically signif-
icant difference between mean sodium value on first and 
second admission day (P value<0.001) the frequency of 
sodium concentration status (hyponatremia, hypernatre-
mia and eunatremia) were not significantly different on 
different days (p=0.47).
There were no statistically significant difference be-
tween the frequency of serum sodium concentration ab-
normalities on the first and second day between men and 
women (p>0.05). Patients were categorized in four age 
groups (25, 26-35, 36-45,>45 years) for sub analysis and 
there was no significant difference in the frequency of se-
rum sodium concentration abnormalities on the first and 
second day in these age groups (p>0.05).
Table 2 has illustrated sodium concentration status 
based on the ingested drugs, severity of toxicity, level of 
consciousness, vomiting after toxicity, alkaline diuresis 
and gastric lavage. There was no statistically significant 
difference on the first and second measurements in these 
groups (p>0.05).
From 184 patients in poisoning ICU, 24 patients (13%) 
were died. In this population 5 (20.8%) were hyponatre-
mic, 3 (12.5%) hypernatremic and 16 (66.7%) eunatremic. 
Variable Number (%)
Age (year)
 ≤ 25 55 (29.9)
26-34 76 (41.3)
35-44 20 (10.9)
 ≥ 45 33 (17.9)
Gender
Male 94 (51.1)
Female 90 (48.9)
Serum sodium con-
centration status
Hyponatremia 21 (11.4)
Eunatremia 152 (82.6)
Hypernatremia 11 (6)
Table 1. Clinical and demographic characteristics of the studied 
patients at the time of admission (n=184)
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There was a statically significant difference in mortality 
based on the ingested drugs (p=0.004).
Outcome was considered as recovery and death. In lo-
gistic regression analysis, age (OR=1.92 ; CI=1.18-3.12 ) 
and severity of toxicity (mild, moderate, and severe based 
on poisoning severity score) (OR=1.32 ; CI=1.12-2.41) 
were predictors of mortality. (Table 3)
4. DISCUSSION
In this study we have evaluated the effect of serum sodi-
um concentration abnormalities on the outcome of thera-
py in critically ill poisoned patients in the first and second 
days of hospitalization. Frequency of hyponatremia and 
hypernatremia were 11.4% and 6% respectively on admis-
sion that hypernatremia decreases to 2.2% in the second 
day. Serum level of sodium in ICU patients has been re-
ported differently in previous studies with different caus-
es of hospitalization. Stelfox and his colleagues studied 
sodium level in post cardiac surgery ICU patients. In their 
study prevalence of hyponatremia was 12% and hyperna-
tremia was 4% (24). The frequency of occurrence of hy-
pernatremia in ICU patients was also 5.7% in a study by 
Polderman (20). Aiyagari evaluated patients of neurologic 
ICU and the frequency of hypernatremia was 7.9% (25). In 
another research was done in France, hyponatremia has 
seen in 14% of ICU patients (26%). However, in another 
study investigated ICU patients, frequency of hyponatre-
mia and hypernatremia was 60.5% and 39.5% respectively 
(27). These differences may be due to the various etiology 
and clinical status of critically ill patients hospitalized in 
different types of ICUs. We studied only poisoning cases 
while the others determined serum sodium level abnor-
malities in all patients hospitalized in ICU with different 
reasons. Hyponatremia occurs due to water retention in 
dysfunction of organs such as kidney (3) and commonly 
may be seen in up to 30-40% of ICU patients (28). mean-
while underlying kidney and liver diseases are not com-
mon in critically ill poisoned ICU patients and altered 
electrolyte balance due to toxicity are usually transient. 
Hence the prevalence of serum sodium concentration ab-
normalities in this group of patients may be anticipated 
less than others.
In our study, there was not any statistical difference in 
the frequency of serum sodium concentration abnormal-
ities based on age and gender or their subgroups. Howev-
er, in an Austrian study on ICU patients for 10 years, it is 
reported that older age and male gender in patients with 
serum sodium concentration abnormalities were risk fac-
tors for increased mortality (2). We also found age as a 
predicting factor in mortality in ICU poisoning patients.
The highest mortality rates were in critically patients 
with herbicide and opiate toxicity. Herbicide toxicity has 
been associated with higher mortality rates in other stud-
ies as well (29, 30). Increased mortality in opiate toxicity 
may be due to the respiratory insufficiency which is previ-
ously been described elsewhere (31-35). This is while the 
statistical analysis of our results does not support that the 
type of the ingested drug is a predictive factor in mortality 
of our critically ill poisoned patients.
In our study age and severity of toxicity were predictors 
of mortality for the poisoned ICU patients which is con-
sistent with a previous Turkish report in a quite similar 
medical setting (36).
Although many studies have confirmed increased mor-
tality in critically ICU patients with hypernatremia (9, 37) 
in our study serum sodium concentration abnormalities 
were not related to increased mortality of the patients. It 
may be due to the differences in demographic and clinical 
characteristics of our cases. Usually most of the poison-
ing cases have not previous history of underlying diseases 
such as kidney and liver disease and the effects of toxin 
in these organs are temporary which could be managed 
successfully.
Our findings showed that serum sodium concentra-
tion abnormalities do not seem to be predictive factors 
for mortality and clinical outcome of therapy in our study 
and mortality was observed more in patients with euna-
tremia.
Variables Na<135 meq/L
135<Na<145 
meq/L
Na>145 
meq/L
P 
value
Age (year) 
≤ 25 4(19%) 47(31.1%) 4(36.4%)
0.17
26-34 7(33.3%) 66(43.7%) 2(18.2%)
35-44 3(14.2%) 16(10.6%) 1(9.1%)
≥ 45 7(33.3%) 22(14.6%) 4(36.4%)
gender
male 10(48%) 79(52%) 5(45.5%)
0.87
female 11(52%) 73(48%) 6(54.5%)
Ingested 
drugs
Opioids 6(28.6%) 38(25.2%) 2(18.2%)
0.82
Psychiatric drugs 7(33.3%) 42(27.8%) 2(18.2%)
Anticonvulsant 1(4.8%) 12(7.9%) 1(9.1%)
insecticide and her-
bicide 4(19%) 21(13.9%) 3(27.3%)
Combination of 
drugs 3(14.3%) 38(25.2%) 3(27.3%)
Poisoning 
severity 
score
mild 4(19%) 33(21.7%) 2(18.2%)
0.37moderate 7(33.3%) 54(35.5%) 1(9.1%)
severe 10(47.7%) 65(42.8%) 8(72.8%)
Level 
of Con-
scious-
ness 
alert 5(23.8%) 17(11.2%) 2(18.2%)
0.12
lethargic 5(23.85) 34(22.4%) 0(0%)
stupor 0(0%) 26(17.1%) 1(9.1)
coma 11(52.4) 75(49.3%) 8(72.8%)
Therapeu-
tic mea-
sures
Without gastric 
lavage 7(33.3%) 38(25.2%) 3(30%)
0.98
Gastric lavage 6(28.6%) 43(28.5%) 2(20%)
Gastric lavage+ 
charcoal 8(38.1%) 65(43%) 5(50%)
Charcoal only 0(0%) 0(0%) 2(20%)
Vomiting 
Yes 3(15%) 30(19.9%) 5(38.4%)
0.71
No 17(85%) 121(80.1%) 8(61.6%)
alkaline 
diuresis
Yes 8(38.1%) 43(28.3%) 4(36.4)
0.68
No 13(61.9%) 109(71.7%) 7(63.3)
Table 2. Serum Sodium (Na+) concentration status based on clin-
ical and demographic characteristics of patients (n=184). Results 
are presented as frequency of patients (and percent).
Variables OR 95% CI P value
Age 1.92 1.18-3.12 0.008
Ingested drugs 0.93 0.79-1.06 0.276
Poisoning Severity 1.32 1.12-2.41 0.024
Gastric lavage 1.03 0.57-1.85 0.92
Level of Consciousness 1.54 0.25-1.15 0.11
Serum Sodium concentration  
status 1.03 0.92-1.51 0.57
Table 3. Predicting factors for patients’ outcome (n=184)
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